Hi, you are logged in as , if you are not , please click here
You are shopping as , if this is not your email, please click here

H01 Introduction to Cancer Clinical Trials & Trial Outcomes: What are we trying to measure? 14/06/27

Info
Location
Attendee Categories
Contact
More Info

Event Information

Clinical Trials
Date of Event
14th June 2027
Last Booking Date for this Event
14th June 2027

Description

This one-day event includes two sessions, which provide a comprehensive introduction to cancer clinical trials for staff new to academic cancer studies.

Introduction to Cancer Clinical Trials (10:00 – 13:00): Participants will get an overview on what clinical trials are, their history and their modern application. The session covers the practical and scientific reasons why we need clinical trials, what are the differences between Phase I, II, III and IV studies and the different methods of randomization. The session also highlights how drug development trials in cancer differ from non-cancer studies and how the new era of targeted therapy and immunotherapy is changing the way cancer trials are designed. 

Trial Outcomes: what are we trying to measure? (14:00 – 17:00): This session, aimed at non-statisticians, will cover the most common primary outcomes measures used in early and late phase cancer trials.

Participants will learn what makes a good outcome measure, how outcomes measures are defined and what data need to be collected to assess the outcome, especially for tumour response assessment and time to event measures such as survival and disease (or progression) free survival. 

A light lunch will be provided.

Time 10.00-17.00

www.ctc.ucl.ac.uk

Attendee CategoryCostPlace(s) Available  
4) Attendees From For-Profit Organisations£80.000